Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Disposal

27 Apr 2006 17:09

Compagnie de Saint-Gobain27 April 2006 April 27, 2006 press release DISPOSAL OF SAINT-GOBAIN CALMAR Saint-Gobain has signed today an agreement regarding the sale of its subsidiarySaint-Gobain Calmar to MeadWestvaco Corporation. Calmar is a leading globalmanufacturer of plastic dispensing and spraying systems for cosmetics andfragrance, personal care as well as pharmaceutical industries. The transaction values Calmar at $745 million (of which $710 million in cashpaid by MeadWestvaco and $35 million of eliminated commitments by Saint-Gobain).In 2005, Calmar reported a pro-forma EBITDA of $72.7 million. Acquired by the Saint-Gobain Group in 1998, Calmar reported pro-forma sales of$403 million in 2005 and has approximately 2,700 employees based in 10production sites. Calmar will benefit from MeadWestvaco's financial capacity and global packagingstrategy, which should support its future development as a major player in itsbusiness. With annual revenues exceeding $6 billion, MeadWestvaco is a leading globalpackaging company that delivers high-value packaging solutions and products tocompanies in the food and beverage, media and entertainment, personal care,cosmetic and healthcare industries. MeadWestvaco employs approximately 23,000people around the world. The completion of the transaction, which is subject to the approval of therelevant anti-trust authorities, should be effective before the end of June2006. As it was communicated following the acquisition of BPB, the Saint-Gobain Groupis implementing a dynamic strategy of active portfolio management, consistentwith its business model. Investor Relations Department Mrs Florence TRIOU-TEIXEIRA Tel.: +33 1 47 62 45 19Mr Alexandre ETUY Tel.: +33 1 47 62 37 15 Fax.: +33 1 47 62 50 62 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Nov 20217:12 amRNSAcquisition
3rd Nov 20215:24 pmRNSProduction capacities expansion
28th Oct 20216:03 pmRNS3rd Quarter Results
20th Oct 20215:05 pmRNSAcquisition
14th Oct 20214:58 pmRNSNew plant in Brazil
6th Oct 20217:10 amRNSNew strategic plan
4th Oct 20217:05 amRNSAcquisition
30th Sep 20215:08 pmRNSAcquisition
29th Sep 20216:13 pmRNSDisposal
31st Aug 20215:07 pmRNSDisposal
29th Jul 20215:10 pmRNSHalf-year Report
12th Jul 20215:17 pmRNSDisposal
5th Jul 20215:07 pmRNSDisposal
11th Jun 20215:08 pmRNSShares cancellation
4th Jun 20215:06 pmRNSNew Executive Committee
3rd Jun 20215:43 pmRNSGENERAL SHAREHOLDERS' MEETING
3rd Jun 20217:24 amRNSTrading update
1st Jun 20214:46 pmRNSDisposal
1st Jun 20217:00 amRNSDisposal
25th May 20215:05 pmRNSNew plant in Malaysia
24th May 20215:05 pmRNSNet-zero carbon plant in Norway
20th May 20215:02 pmRNSAcquisition
17th May 20215:19 pmRNSNew plant in China
17th May 20217:07 amRNSAcquisition
11th May 20215:09 pmRNSAcquisition
29th Apr 20215:01 pmRNS1st Quarter Results
16th Apr 20217:07 amRNSDisposal
14th Apr 20217:07 amRNSInternal carbon fund
6th Apr 20217:06 amRNSNew facility
22nd Mar 20215:09 pmRNSAgreement
15th Mar 20215:40 pmRNSAcquisition
3rd Mar 20217:04 amRNSNew facility
25th Feb 20215:06 pmRNSFull-Year Results
6th Jan 20215:12 pmRNSSecond Half Results
5th Jan 20217:00 amRNSDisposal
14th Dec 20207:06 amRNSAcquisition
1st Dec 20207:20 amRNSShares cancellation
26th Nov 20205:06 pmRNSDividend Declaration
12th Nov 20207:25 amRNSSaint-Gobain sets out its CO2 roadmap
9th Nov 20205:08 pmRNSDisposal
3rd Nov 20204:53 pmRNSCancellation of shares
29th Oct 20204:58 pmRNS3rd Quarter Results
13th Oct 202011:09 amRNSFrench stimulus plan
2nd Sep 20207:05 amRNSAcquisition
13th Aug 20204:54 pmRNSShares cancellation
30th Jul 20205:59 pmRNSH1-2020 Results
4th Jun 20206:00 pmRNSAGM Statement
27th May 20207:48 amRNSCompletion of sale of Sika shares for CHF2.56 bn
26th May 20205:45 pmRNSABB placement of Sika shares
23rd Apr 20204:52 pmRNS1st Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.